首页> 外国专利> COMPOUND OF THE FORMULA OR A PHYSIOLOGICALLY ACCEPTABLE SOLVATE, USE OF THE SAME, PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL FORMULATION, METHOD FOR THE TREATMENT OF A HUMAN OR ANIMAL INJURY AND A PRELIMINAL AND ALPHERIC ALTERIUM OR CONDITION,

COMPOUND OF THE FORMULA OR A PHYSIOLOGICALLY ACCEPTABLE SOLVATE, USE OF THE SAME, PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL FORMULATION, METHOD FOR THE TREATMENT OF A HUMAN OR ANIMAL INJURY AND A PRELIMINAL AND ALPHERIC ALTERIUM OR CONDITION,

机译:配方或生理上可接受的溶剂化物的组合,相同的使用,药物成分,药物配方,治疗人或动物伤害的方法以及首要的和Alternate或状况,

摘要

"compound of the formula or a physiologically acceptable solvate thereof, use thereof, pharmaceutical composition, pharmaceutical formulation, method for treating a human or animal subject with an inflammatory and / or allergic condition, and process for preparing a compound or an thereof solvate ". According to one aspect of the invention there is provided a compound of formula (I) and solvates thereof. Also provided are compositions containing the compound, processes for preparing it, and its use in therapy.
机译:“式的化合物或其生理上可接受的溶剂化物,其用途,药物组合物,药物制剂,用于治疗具有炎性和/或过敏性病症的人或动物受试者的方法以及制备化合物或其溶剂化物的方法”。根据本发明的一个方面,提供了式(I)的化合物及其溶剂化物。还提供了包含该化合物的组合物,其制备方法及其在治疗中的用途。

著录项

  • 公开/公告号BRPI0113042B1

    专利类型

  • 公开/公告日2018-02-14

    原文格式PDF

  • 申请/专利权人 GLAXO GROUP LIMITED;

    申请/专利号BR2001PI13042

  • 申请日2001-08-03

  • 分类号A61K9/12;A61K31/58;A61K9/14;A61K31/56;A61K45;A61K47/06;A61K47/18;A61K47/36;A61P5/44;A61P11/06;A61P11/08;A61P29;A61P37/08;A61P43;C07J17;C07J31;C07J33;C07J43;

  • 国家 BR

  • 入库时间 2022-08-21 12:53:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号